pharma · Hypertension · Breast Neoplasms
Pfizer
Pfizer clinical programs — 58 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- New York 10017, US
- Employees
- 103,316
- Programs
- 98
- Drugs
- 80
- Patents
- 0
Pfizer projects
58 ClinicalTrials.gov programs sponsored by Pfizer.
Pfizer has 58 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
gabapentin
Pfizer
Epilepsies, Partial
1 trial -
inotuzumab ozogamicin
Pfizer
Lymphoma, Follicular
1 trial -
olmesartan alone or in combination with hydrochlorothiazide
Pfizer
Essential Hypertension
1 trial -
pegaptanib sodium
Pfizer
Macular Degeneration
1 trial -
placebo
Pfizer
Schizophrenia
1 trial -
pregabalin
Pfizer
Partial Seizures
2 trials -
pregabalin
Pfizer
Neuropathy
1 trial -
sildenafil
Pfizer
Hypertension, Pulmonary
1 trial -
sunitinib malate
Pfizer
Carcinoma, Hepatocellular
1 trial -
talazoparib plus enzalutamide
Pfizer
Prostate Cancer
1 trial
Frequently asked questions
How many clinical projects does Pfizer have?
58 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.